Contained Liquid System Refilling Aerosol Devices A1 Patent
Summary
The USPTO published patent application US20260108684A1 for a contained liquid system designed for refilling aerosol delivery devices. The system includes a housing storing aerosol precursor composition, an adapter with a valve for sealed connection to the aerosol delivery device, separate filling and airflow ports, and a child-resistant cap with two-tab mechanism requiring simultaneous pressing for removal. The application (No. 19323689) was filed on September 9, 2025, with inventors John Brice O'Brien, Frederic Philippe Ampolini, and James William Rogers. Patent applications are published to provide public notice and do not yet confer enforceable rights.
“A container for refilling an aerosol delivery device includes a housing storing an aerosol precursor composition.”
About this source
USPTO classification A61M covers devices that introduce or withdraw fluids from the body: infusion pumps, catheters, syringes, inhalers, wound drainage, dialysis equipment, and fluid-handling microfluidics. Every newly published application in A61M lands in this feed, around 205 a month. Applications publish 18 months after filing. Watch this if you compete in infusion therapy or drug delivery, file freedom-to-operate analyses for medical device startups, scout acquisition targets in cardiovascular or respiratory devices, or track hospital R&D arms that are quietly patenting clinical innovations.
What changed
The USPTO published patent application US20260108684A1 for a contained liquid system designed for refilling aerosol delivery devices. The system includes a housing storing aerosol precursor composition, an adapter with a valve for sealed connection to the aerosol delivery device, separate filling and airflow ports, and a child-resistant cap with two-tab mechanism requiring simultaneous pressing for removal.
Manufacturers of aerosol delivery devices and refill systems should review this application for competitive intelligence purposes. Patent applications represent early-stage intellectual property filings that may signal future market entry by competitors or potential licensing opportunities, but do not create immediate compliance obligations.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
CONTAINED LIQUID SYSTEM FOR REFILLING AEROSOL DELIVERY DEVICES
Application US20260108684A1 Kind: A1 Apr 23, 2026
Inventors
John Brice O'Brien, Frederic Philippe Ampolini, James William Rogers
Abstract
A container for refilling an aerosol delivery device includes a housing storing an aerosol precursor composition. An adapter coupled to the housing is removably, sealably connectable with the aerosol delivery device for refilling with aerosol precursor composition, and includes a valve engageable with the aerosol delivery device. The aerosol delivery device defines separate and distinct filling and airflow ports, the filling port for transfer of aerosol precursor composition into the aerosol delivery device during refilling, wherein the airflow port is closed by the valve to prevent passing of the aerosol precursor composition therethrough, and the airflow port for a flow of air through the aerosol delivery device when the valve and aerosol delivery device are disengaged. A cap is removably coupled to the housing over the adapter, the cap being a removal-resistant cap including two tabs, the simultaneous pressing of which allows the removal-resistant cap to turn and be removed.
CPC Classifications
A61M 15/06 A24F 40/485 A61M 11/042 B65B 3/04 B65B 31/00 A24F 15/015 A24F 40/10 A61M 2209/045
Filing Date
2025-09-09
Application No.
19323689
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.